N-methyl-N-[1-[1-[5-methyl-6-(1,2,3,4-tetrahydronaphthalen-2-ylmethylamino)pyrimidine-4-carbonyl]piperidin-4-yl]piperidin-4-yl]methanesulfonamide | 1232055-46-7

• 分子结构分类: 有机化合物 - 苯类化合物 - 四氢化萘
• 英文名称: N-methyl-N-[1-[1-[5-methyl-6-(1,2,3,4-tetrahydronaphthalen-2-ylmethylamino)pyrimidine-4-carbonyl]piperidin-4-yl]piperidin-4-yl]methanesulfonamide
• CAS: 1232055-46-7
• 化学式: C₂₉H₄₂N₆O₃S
• 分子量: 554.757
• InChiKey: YSOIFZQAXOVWOG-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.7
• 重原子数：
  39
• 可旋转键数：
  7
• 环数：
  5.0
• sp3杂化的碳原子比例：
  0.62
• 拓扑面积：
  107
• 氢给体数：
  1
• 氢受体数：
  8

文献信息

• [EN] CYCLIC PYRIMIDIN-4-CARBOXAMIDES AS CCR2 RECEPTOR ANTAGONISTS FOR TREATMENT OF INFLAMMATION, ASTHMA AND COPD<br/>[FR] PYRIMIDINE-4 CARBOXAMIDES CYCLIQUES EN TANT QU'ANTAGONISTES DU RÉCEPTEUR CCR2 POUR LE TRAITEMENT D'INFLAMMATIONS, DE L'ASTHME ET DES BRONCHO-PNEUMOPATHIES CHRONIQUES OBSTRUCTIVES
  申请人：BOEHRINGER INGELHEIM INT

  公开号：WO2010070032A1

  公开（公告）日：2010-06-24

  The present invention relates to novel antagonists for CCR2 (CC chemokine receptor 2) and their use for providing medicaments for treating conditions and diseases, especially pulmonary diseases like asthma and COPD. Formula (I), wherein A is selected from among a single bond, =CH-, -CH2-, -O-, -S-, and -NH-; wherein n is 1, 2 or 3; wherein Z is C or N, the other variables are as defined in the claims, as well as in form of their acid addition salts with pharmacologically acceptable acids.

  本发明涉及用于治疗疾病和疾病的新型CCR2（CC趋化因子受体2）拮抗剂及其用途，特别是用于治疗肺部疾病如哮喘和慢性阻塞性肺病的药物。公式（I），其中A从单键，=CH-，-CH2-，-O-，-S-和-NH-中选择；其中n为1、2或3；其中Z为C或N，其他变量如声明中所定义，以及以药理学上可接受的酸的酸盐形式存在。
• CYCLIC PYRIMIDIN-4-CARBOXAMIDES AS CCR2 RECEPTOR ANTAGONISTS FOR TREATMENT OF INFLAMMATION, ASTHMA AND COPD
  申请人：Boehringer Ingelheim International GmbH

  公开号：EP2379525B1

  公开（公告）日：2015-07-29
• PROCESS AND INTERMEDIATES FOR THE PRODUCTION OF CCR2 ANTAGONISTS
  申请人：EBEL Heiner

  公开号：US20140336374A1

  公开（公告）日：2014-11-13

  The present invention relates to a process for the production of novel antagonists for CCR2 (CC chemokine receptor 2) and intermediates thereof.
• US8835440B2
  申请人：——

  公开号：US8835440B2

  公开（公告）日：2014-09-16